Press Kit

Thank you for your interest in iGuard. We hope you find the www.iGuard.org site helpful and are excited about helping us to improve drug safety.

In order to obtain a copy of our press kit, please click here to download the most recent version in PDF format, or contact:

Mari Mansfield
Head of Communications
iGuard
66 Witherspoon St #262
Princeton NJ
08542 USA

E-mail: media@iGuard.org

Over 1/2 MILLION Americans have chosen iGUARD.org to monitor their medications.

DISCLAIMER: iGuard.org is not intended to be a substitute for professional medical advice. iGuard cannot and does not take into consideration every possible interaction or account for individual responses to medicine. Different individuals may respond to medication in different ways. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective, or appropriate for any given patient. Always seek the advice of a qualified health provider with any questions you may have before making any changes to your treatment. The use of the iGuard site and its content is at your own risk. The iGuard site and the information contained in it is intended for users in the United States and information in other countries may be different.